CTOs on the Move

Albireo Pharma

www.albireopharma.com

 
Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. Albireo`s lead product candidate, A4250, is directed to treat rare pediatric cholestatic liver diseases and is in Phase 3 development in its initial target indication, progressive familial intrahepatic cholestasis. Albireo`s clinical pipeline also includes two Phase 2 product candidates. Albireo`s elobixibat, approved in Japan for the treatment of chronic constipation, is the first ileal bile acid transporter (IBAT) inhibitor approved anywhere in the world. Albireo was ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Joan Connolly
Chief Technology Officer Profile
Tyson Kamikawa
Vice President Information Technology Profile

Similar Companies

Olympus Biotech Corporation

Olympus Biotech Corporation is a Hudson, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Meda

Meda is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FloraWorks

FloraWorks is a biotech enterprise that specializes in discovering rare and novel cannabinoids for commercial and therapeutic applications. They develop and patent scaled manufacturing pathways for cannabinoids with a high potential for therapeutic use...

Comparative Biosciences Inc

Comparative Biosciences Inc is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hollister Stier

Hollister Stier is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.